Search results
Cycle Pharmaceuticals offers to acquire Vanda Pharma for $466m
Pharmaceutical Technology via Yahoo Finance· 9 hours agoThe company also reported net sales of $109m and an operating profit of $40m in 2023. Cycle ...
Acid for the ear
Politico· 2 hours agoThe Pentagon is investigating how psychedelic medicine can help servicemembers — beyond mental health issues. The agency has awarded $825,000 to...
Initial public offerings scheduled to debut next week
Houston Chronicle· 12 minutes agoThe following is a list of initial public offerings planned for the coming week. Proposed Nasdaq symbol TEM. Business: Provides data and analytics tools for precision medicine. Proposed Nasdaq symbol TLX.
British drugmaker seeks to acquire D.C. biotech for $466M - Washington Business Journal
The Business Journals· 3 hours agoJust two weeks after formally rejecting one unsolicited acquisition offer, D.C.-based Vanda ...
Democrats ramp up patent fight with drug industry in bid to lower prices
Washington Post· 4 hours agoSen. Elizabeth Warren (D-Mass.) and Rep. Pramila Jayapal (D-Wash.) this week wrote to eight ...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 5 hours agoThe application was based on data from the FLAURA2 phase III study. Tagrisso was approved for...
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Buy by Jefferies Financial Group
ETF DAILY NEWS· 12 hours agoCollegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a report released ...
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $21.00 at Barclays
ETF DAILY NEWS· 16 hours agoTeva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its price target upped by Barclays from $20.00 to $21.00 in a research note issued to investors on Wednesday ...
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Brokerages
ETF DAILY NEWS· 17 hours agoFusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) has been assigned a consensus rating of...
Changing Your Diet and Lifestyle May Slow Down Alzheimer's
Time via AOL· 18 hours agoAdministration is expected to make a decision about another such promising therapy. But in addition...
